Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: United Kingdom Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20062
20075
20083
20093
20115
20125
20132
20142
20157
20164
20175
20188
20199
20203
20215
20223
20237
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Novartis Pharmaceuticals5
Seagen Inc.5
Bristol-Myers Squibb4
GlaxoSmithKline4
Bayer3
Clovis Oncology, Inc.3
Hoffmann-La Roche3
Seagen, a wholly owned subsidiary of Pfizer3
Bioven Europe2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung84
Lung Neoplasms15
Melanoma14
Squamous Cell Carcinoma of Head and Neck12
Neoplasms11
Neoplasm Metastasis10
Stomach Neoplasms10
Triple Negative Breast Neoplasms10
Carcinoma, Renal Cell9
Ovarian Neoplasms9

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.